The Arab Drug Company (EGX: ADCI)
Egypt
· Delayed Price · Currency is EGP 103.27
0.00 (0.00%)
At close: Oct 14, 2024
The Arab Drug Company Cash Flow Statement
Financials in millions EGP. Fiscal year is July - June.
Millions EGP. Fiscal year is Jul - Jun.
Fiscal Year | TTM | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | 2019 - 2015 |
|---|---|---|---|---|---|---|---|
Period Ending | Jun '24 Jun 30, 2024 | Jun '24 Jun 30, 2024 | Jun '23 Jun 30, 2023 | Jun '22 Jun 30, 2022 | Jun '21 Jun 30, 2021 | Jun '20 Jun 30, 2020 | 2019 - 2015 |
| Net Income | 102.82 | 102.82 | 82.77 | 76.3 | 101.41 | 92.8 | Upgrade
|
| Depreciation & Amortization | 10.91 | 10.91 | 3.26 | 9.39 | 7.81 | 0.73 | Upgrade
|
| Other Operating Activities | 22.03 | 22.03 | 1.48 | -52.82 | -72.65 | -20.3 | Upgrade
|
| Operating Cash Flow | 135.77 | 135.77 | 87.51 | 32.87 | 36.58 | 73.24 | Upgrade
|
| Operating Cash Flow Growth | 55.15% | 55.15% | 166.22% | -10.14% | -50.05% | 99.96% | Upgrade
|
| Capital Expenditures | -218.95 | -218.95 | -63.18 | -89.92 | -28.87 | -2.53 | Upgrade
|
| Investment in Securities | -67.03 | -67.03 | - | 13.88 | - | -0.7 | Upgrade
|
| Other Investing Activities | 27.92 | 27.92 | 1.07 | 1.63 | 4.34 | 1.84 | Upgrade
|
| Investing Cash Flow | -258.07 | -258.07 | -62.11 | -74.41 | -24.53 | -1.4 | Upgrade
|
| Short-Term Debt Issued | - | - | - | 27.33 | - | - | Upgrade
|
| Long-Term Debt Issued | 339.09 | 339.09 | 51.3 | 52.54 | - | - | Upgrade
|
| Total Debt Issued | 339.09 | 339.09 | 51.3 | 79.87 | - | - | Upgrade
|
| Long-Term Debt Repaid | -44.55 | -44.55 | - | - | - | - | Upgrade
|
| Total Debt Repaid | -44.55 | -44.55 | - | - | - | - | Upgrade
|
| Net Debt Issued (Repaid) | 294.54 | 294.54 | 51.3 | 79.87 | - | - | Upgrade
|
| Common Dividends Paid | -36.1 | -36.1 | -37.49 | -43.54 | -38.85 | -32.2 | Upgrade
|
| Other Financing Activities | -23.09 | -23.09 | -1.68 | -0.95 | - | - | Upgrade
|
| Financing Cash Flow | 235.35 | 235.35 | 12.13 | 35.38 | -38.85 | -32.2 | Upgrade
|
| Miscellaneous Cash Flow Adjustments | 69.18 | 69.18 | -27.33 | - | -0 | - | Upgrade
|
| Net Cash Flow | 182.24 | 182.24 | 10.2 | -6.15 | -26.8 | 39.64 | Upgrade
|
| Free Cash Flow | -83.19 | -83.19 | 24.33 | -57.04 | 7.71 | 70.7 | Upgrade
|
| Free Cash Flow Growth | - | - | - | - | -89.10% | 123.21% | Upgrade
|
| Free Cash Flow Margin | -10.59% | -10.59% | 3.84% | -11.30% | 1.44% | 13.58% | Upgrade
|
| Free Cash Flow Per Share | -13.86 | -13.86 | 4.05 | -8.42 | 1.11 | 9.52 | Upgrade
|
| Cash Interest Paid | 23.09 | 23.09 | 1.68 | 0.95 | - | - | Upgrade
|
| Cash Income Tax Paid | 34.73 | 34.73 | 35.09 | 51.95 | 52.97 | 24.45 | Upgrade
|
| Levered Free Cash Flow | -110.04 | -110.04 | -24.95 | -121.56 | -1.96 | 51.41 | Upgrade
|
| Unlevered Free Cash Flow | -95.61 | -95.61 | -23.5 | -120.96 | -1.93 | 51.41 | Upgrade
|
| Change in Net Working Capital | -38.62 | -38.62 | 24.26 | 97.17 | 57.25 | 20.09 | Upgrade
|
Source: S&P Capital IQ. Standard template. Financial Sources.